Results 171 to 180 of about 13,720 (213)

Markers of fibrosis, inflammation, and remodeling pathways in heart failure [PDF]

, 2015
BARISON, ANDREA, BORRELLI, CHIARA, CLERICO, ALDO, EMDIN, MICHELE, Gabutti, A, PASSINO, Claudio, VERGARO, Giuseppe   +6 more
core   +1 more source

The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing. [PDF]

Biomedicines
Dudek M, Kałużna-Oleksy M, Sawczak F, Kukfisz A, Soloch A, Migaj J, Lesiak M, Straburzyńska-Migaj E.   +7 more
europepmc   +1 more source

Correlations between soluble ST2 concentration and the nutritional status in patients with heart failure with reduced ejection fraction - cross-sectional study. [PDF]

Cardiol J
Kałużna-Oleksy M, Waśniewski F, Waśniewski F, Szczechla M, Sawczak F, Kukfisz A, Krysztofiak H, Przytarska K, Straburzyńska-Migaj E, Dudek M.   +9 more
europepmc   +1 more source

Mast cells control lung type 2 inflammation via prostaglandin E₂-driven soluble ST2. [PDF]

Immunity
Alhallak K, Nagai J, Zaleski K, Marshall S, Salloum T, Derakhshan T, Hayashi H, Feng C, Kratchmarov R, Lai J, Kuchibhotla V, Nishida A, Balestrieri B, Laidlaw T, Dwyer DF, Boyce JA.   +15 more
europepmc   +1 more source

Is soluble ST2 a new marker in heart failure?

, 2018
The clinical diagnosis of heart failure (HF) is based on a history and a physical examination. Circulating molecules, suchas troponin, B-type natriuretic peptide, and N-terminal pro-B-type natriuretic peptide are useful in the management ofHF. Recently, it has been reported that a new biomarker, suppression of tumorigenicity (ST2), was associated with ...
openaire   +1 more source

Soluble ST2 for predicting heart failure, atrial fibrillation and death in patients with coronary heart disease with or without renal insufficiency. [PDF]

Heliyon
Li H, Zhu Q, Bai J, Chen J, Zhu Z, Hao B, Wang W, Bai Y, Liu H.   +8 more
europepmc   +1 more source

Soluble ST2 for Prognosis and Monitoring in Heart Failure

Journal of the American College of Cardiology, 2017
Antoni Bayés-Genís, Julio Núñez, Josep Lupón   +2 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Soluble ST2 in Heart Failure

Heart Failure Clinics, 2018
Suppression of tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family, whose role was originally established in the context of inflammatory and autoimmune diseases. More recently, testing for ST2 has been used in the setting of cardiovascular disease.
Cian P, McCarthy, James L, Januzzi
openaire   +4 more sources